Semax is a synthetic heptapeptide belonging to the class of melanocortin derivatives. Structurally, it is an analog of adrenocorticotropic hormone (ACTH 4-10), modified to increase stability and resistance to enzymatic degradation. This structural adaptation allows researchers to investigate its activity in controlled laboratory settings with greater consistency compared to native peptide fragments.
Semax has been studied for its interactions with the central nervous system and its potential role in modulating neurochemical pathways. Research has explored its impact on neurotransmitter regulation, neuronal plasticity, and gene expression associated with neurotrophic factors. In experimental models, Semax is often evaluated for its potential to influence cognitive function, stress response, and neuroprotection.
